Esophageal Neoplasms
Information
- Disease name
- Esophageal Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03429816 | Active, not recruiting | N/A | OPPOSITE: Outcome Prediction Of Systemic Treatment in Esophagogastric Carcinoma | April 15, 2018 | November 2023 |
| NCT03153280 | Active, not recruiting | Phase 1 | Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer | January 13, 2022 | December 2026 |
| NCT02279134 | Active, not recruiting | Phase 2/Phase 3 | Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma | October 2014 | December 2024 |
| NCT00153881 | Completed | Phase 1 | Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer | February 2000 | September 2013 |
| NCT00160030 | Completed | Phase 2 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | September 2004 | |
| NCT00183872 | Completed | Phase 2 | Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma | April 14, 2005 | October 20, 2015 |
| NCT00041808 | Completed | Phase 1/Phase 2 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | July 2001 | April 2003 |
| NCT00042510 | Completed | Phase 2 | Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer | August 2000 | July 2004 |
| NCT00054873 | Completed | Phase 2 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | November 2003 | December 2004 |
| NCT00213486 | Completed | Phase 2 | Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial | June 2002 | December 2004 |
| NCT00259402 | Completed | Phase 2 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | February 2000 | October 2008 |
| NCT00335010 | Completed | N/A | Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction | May 2005 | December 2005 |
| NCT00374985 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction | October 2005 | September 2013 |
| NCT00390416 | Completed | Phase 2 | Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma | October 2006 | January 2012 |
| NCT00447330 | Completed | Phase 2 | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma | February 2007 | July 2014 |
| NCT00515216 | Completed | Phase 2 | Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors | August 2007 | November 2013 |
| NCT00813072 | Completed | Phase 2 | Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | November 2007 | December 2010 |
| NCT00907543 | Completed | N/A | Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial | April 2009 | December 31, 2018 |
| NCT00909402 | Completed | Phase 1 | A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas | November 2009 | November 2012 |
| NCT01047111 | Completed | N/A | Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001) | May 2010 | July 2017 |
| NCT01139229 | Completed | N/A | Hybrid-everted Versus Hand-sewn or Stapled Esophagogastrostomy in Prevention of Anastomotic Stricture | November 2007 | September 2008 |
| NCT01156831 | Completed | PET-CT Based Radiotherapy in Esophageal Cancer Patients | November 2007 | May 2013 | |
| NCT01267305 | Completed | N/A | The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery | January 2011 | August 2013 |
| NCT01670409 | Completed | Phase 2 | Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer | August 2012 | August 2015 |
| NCT01719926 | Completed | Phase 1 | Phase I Platinum Based Chemotherapy Plus Indomethacin | September 2012 | August 2017 |
| NCT01807936 | Completed | N/A | Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002) | March 20, 2013 | November 2019 |
| NCT01870817 | Completed | N/A | Home Jejunostomy Feeding Following Esophagectomy/Gastrectomy | July 2012 | August 2014 |
| NCT01900691 | Completed | N/A | Removal of the Evolution® Esophageal Stent - Fully Covered | September 2013 | December 10, 2018 |
| NCT01928290 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer | November 8, 2013 | October 28, 2019 |
| NCT02013154 | Completed | Phase 1 | A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab | May 5, 2014 | January 11, 2021 |
| NCT02030769 | Completed | N/A | Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer | January 2014 | December 2014 |
| NCT02128243 | Completed | Phase 2 | Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer | September 2014 | October 8, 2020 |
| NCT02182804 | Completed | N/A | A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer | February 2013 | June 2014 |
| NCT02253602 | Completed | N/A | Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer | September 2014 | May 2018 |
| NCT02284802 | Completed | N/A | Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy | September 10, 2014 | March 10, 2023 |
| NCT02305043 | Completed | Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer | March 2014 | January 31, 2018 | |
| NCT02330536 | Completed | N/A | Cardiopulmonary Effects of Intrathoracic Pressure Overshoot During Carbon Dioxide Insufflation in Thoracoscopic Surgery | December 2014 | July 2020 |
| NCT02359968 | Completed | Phase 2 | PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer | February 26, 2015 | February 9, 2024 |
| NCT02378948 | Completed | N/A | Nutritional Route In Esophageal Resection Trial II | October 2015 | November 2018 |
| NCT02381249 | Completed | N/A | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | March 2015 | March 2018 |
| NCT02385604 | Completed | The Predictive Value of CT-PET in Esophageal Cancer | January 2014 | January 2016 | |
| NCT02385617 | Completed | N/A | Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer | January 2014 | December 2017 |
| NCT02385630 | Completed | N/A | Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer | March 2015 | July 2018 |
| NCT02406170 | Completed | Phase 1/Phase 2 | Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma | April 2015 | October 2019 |
| NCT02429622 | Completed | Phase 1/Phase 2 | Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma | January 2015 | December 2016 |
| NCT02430701 | Completed | N/A | Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms | January 1, 2015 | April 1, 2021 |
| NCT02446574 | Completed | Phase 1/Phase 2 | Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma | July 2007 | December 2016 |
| NCT02642809 | Completed | Phase 1 | Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers | June 8, 2016 | August 3, 2021 |
| NCT02676791 | Completed | N/A | Influence of Esophageal Washout on Local Carcinoma Recurrence After Curative Resection | February 16, 2016 | September 24, 2021 |
| NCT02703142 | Completed | Endoscopic Evaluation After Esophagectomy | October 2015 | October 2016 | |
| NCT02721563 | Completed | Phase 4 | A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC | February 25, 2016 | June 30, 2018 |
| NCT02845479 | Completed | Phase 3 | The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I | December 7, 2018 | December 7, 2020 |
| NCT02911363 | Completed | N/A | Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma | January 2016 | August 2018 |
| NCT02937389 | Completed | Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After Esophagectomy | May 2015 | November 2019 | |
| NCT03187314 | Completed | Phase 2 | Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer | June 14, 2017 | June 30, 2019 |
| NCT03189719 | Completed | Phase 3 | First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590) | July 25, 2017 | July 10, 2023 |
| NCT03261947 | Completed | Phase 2 | A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors | October 25, 2017 | August 24, 2020 |
| NCT03274011 | Completed | Phase 2 | Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma | July 1, 2017 | June 26, 2019 |
| NCT03388047 | Completed | N/A | Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus | January 1, 2018 | December 31, 2020 |
| NCT03549494 | Completed | Phase 2 | Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | October 25, 2018 | February 15, 2023 |
| NCT03829098 | Completed | TreatmENT of AnastomotiC Leakage After Esophagectomy | April 1, 2019 | December 31, 2019 | |
| NCT04466592 | Completed | N/A | Health and Employment After Gastro Intestinal Surgery - HEAGIS1 | December 13, 2019 | April 30, 2021 |
| NCT04547881 | Completed | Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD) | December 12, 2016 | February 4, 2022 | |
| NCT04973046 | Completed | Tissue Oxygen Saturation for Esophagectomy | November 1, 2020 | April 30, 2021 | |
| NCT04994548 | Completed | Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension | January 1, 2005 | March 31, 2021 | |
| NCT05194371 | Completed | Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China | June 1, 2021 | December 15, 2021 | |
| NCT05303740 | Completed | Anlotinib Retrospective Study for Esophageal Cancer | January 1, 2019 | March 1, 2022 | |
| NCT05680077 | Completed | KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method) | October 28, 2022 | October 31, 2023 | |
| NCT05740852 | Completed | Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer | January 1, 2016 | January 31, 2023 | |
| NCT06381583 | Completed | A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma | April 15, 2023 | April 24, 2024 | |
| NCT06445972 | Not yet recruiting | Phase 1/Phase 2 | Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) | July 1, 2024 | October 27, 2028 |
| NCT06380816 | Not yet recruiting | Phase 1/Phase 2 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | May 2024 | November 2029 |
| NCT05898828 | Recruiting | Phase 1/Phase 2 | Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer | June 23, 2024 | December 30, 2036 |
| NCT04976634 | Recruiting | Phase 2 | Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) | August 18, 2021 | March 22, 2027 |
| NCT05252078 | Recruiting | Phase 2 | Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | June 2, 2022 | November 2026 |
| NCT05688020 | Recruiting | Phase 4 | Tranexamic Acid During Upper GI Endoscopic Resection Procedures | February 1, 2023 | February 2026 |
| NCT05688176 | Recruiting | Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers | June 2016 | January 31, 2027 | |
| NCT05591053 | Recruiting | N/A | Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans | April 1, 2023 | January 2025 |
| NCT06077981 | Recruiting | N/A | Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections | June 19, 2023 | March 13, 2025 |
| NCT05349045 | Recruiting | Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer | May 5, 2022 | May 5, 2025 | |
| NCT06365866 | Recruiting | N/A | Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. | February 19, 2024 | December 2024 |
| NCT02530983 | Recruiting | Mayo Clinic Upper Digestive Disease Survey | August 2015 | December 2025 | |
| NCT04359732 | Recruiting | N/A | Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI | May 8, 2020 | June 30, 2025 |
| NCT05944237 | Recruiting | Phase 1/Phase 2 | HTL0039732 in Participants With Advanced Solid Tumours | July 13, 2023 | September 2026 |
| NCT05619016 | Recruiting | Phase 2 | [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors | November 23, 2022 | December 31, 2025 |
| NCT05698992 | Recruiting | Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer | February 27, 2023 | December 31, 2027 | |
| NCT04513418 | Recruiting | Phase 3 | Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant Chemoradiotherapy | November 10, 2020 | December 2028 |
| NCT06027515 | Recruiting | N/A | Esophageal Cancer Multimodal Prehabilitation Study | December 1, 2023 | January 31, 2026 |
| NCT03222895 | Recruiting | Distribution of Lymph Node Metastases in Esophageal Carcinoma | March 1, 2019 | June 1, 2028 | |
| NCT03231462 | Recruiting | Impact of Perioperative Physical Activity on Postoperative Pulmonary Complications and Quality of Life Among Esophageal Cancer Patients | March 6, 2015 | December 31, 2024 | |
| NCT05624099 | Recruiting | Phase 2 | Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. | August 1, 2023 | December 31, 2027 |
| NCT05768282 | Recruiting | Phase 4 | Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia | January 1, 2016 | December 31, 2025 |
| NCT06070376 | Recruiting | N/A | Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus. | June 26, 2023 | August 26, 2026 |
| NCT05800054 | Recruiting | N/A | Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer | January 1, 2021 | December 31, 2027 |
| NCT06086457 | Recruiting | Phase 3 | PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer | February 4, 2024 | August 28, 2029 |
| NCT05804331 | Recruiting | The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study | March 14, 2023 | September 14, 2028 | |
| NCT05007106 | Recruiting | Phase 2 | MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) | September 16, 2021 | February 22, 2027 |
| NCT05875870 | Recruiting | N/A | Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer | July 24, 2023 | May 15, 2028 |
| NCT00048529 | Suspended | Phase 2 | Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus | September 2002 | |
| NCT04908111 | Suspended | Phase 1/Phase 2 | A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 | December 8, 2021 | December 2027 |
| NCT00760604 | Terminated | Phase 3 | A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer | September 2008 | April 2012 |
| NCT04945733 | Terminated | Phase 2 | A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer | August 30, 2021 | July 3, 2023 |
| NCT01572987 | Terminated | N/A | Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus | September 2011 | May 2017 |
| NCT03540953 | Terminated | N/A | Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis | January 5, 2015 | January 5, 2018 |
| NCT00559351 | Terminated | Phase 3 | RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | December 2001 | April 2004 |
| NCT00321958 | Terminated | Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer | April 2006 | May 2007 | |
| NCT00560846 | Terminated | N/A | Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery | November 2007 | September 2012 |
| NCT02721576 | Terminated | Phase 4 | A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC | July 5, 2016 | July 30, 2018 |
| NCT00341523 | Terminated | Early Detection of Esophageal Cancer | November 1, 2016 | April 29, 2024 | |
| NCT00368329 | Terminated | Phase 1 | Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer | June 2006 | March 2009 |
| NCT02584400 | Terminated | Phase 2 | Tumor Hypoxia With HX4 PET in Several Diseases | May 2016 | May 2017 |
| NCT04510285 | Terminated | Phase 2 | A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection | August 10, 2020 | December 30, 2022 |
| NCT00586404 | Terminated | The Study of Barrett's Esophagus: What Are the Factors of Progression | November 2007 | May 2017 | |
| NCT02721550 | Terminated | Phase 4 | A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC | August 1, 2016 | June 30, 2018 |
| NCT00383266 | Terminated | Phase 2 | A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer | October 2006 | June 2010 |
| NCT03223662 | Terminated | Phase 2 | Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy | October 31, 2017 | July 27, 2018 |
| NCT00442507 | Terminated | Phase 2 | Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction | March 2007 | January 2009 |
| NCT04665921 | Terminated | Phase 1 | A Study of SGN-STNV in Advanced Solid Tumors | January 18, 2021 | March 1, 2024 |
| NCT00094978 | Terminated | Phase 1 | Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum | October 25, 2004 | May 20, 2013 |
| NCT02859415 | Terminated | Phase 1/Phase 2 | Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases | August 8, 2019 | December 1, 2021 |
| NCT00190554 | Terminated | Phase 3 | A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma | May 2000 | May 2009 |
| NCT02418052 | Unknown status | N/A | Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE | January 2014 | December 2016 |
| NCT02604615 | Unknown status | Phase 3 | The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy | October 2014 | December 2020 |
| NCT02644863 | Unknown status | Phase 2 | Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer | December 2015 | May 2019 |
| NCT02858206 | Unknown status | Phase 2 | Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma | June 2016 | November 2021 |
| NCT02891083 | Unknown status | Phase 3 | Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer | January 2016 | January 2021 |
| NCT02908204 | Unknown status | Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma | October 2016 | ||
| NCT02937519 | Unknown status | Phase 2 | Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer | June 2015 | June 2018 |
| NCT03011255 | Unknown status | Phase 2 | Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer | December 2016 | December 2019 |
| NCT03065257 | Unknown status | Endoscopic Resection Multicenter Registry | March 15, 2017 | April 2020 | |
| NCT00057395 | Unknown status | Phase 1/Phase 2 | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies | ||
| NCT03200691 | Unknown status | Phase 2 | Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma | August 10, 2017 | July 1, 2020 |
| NCT03254511 | Unknown status | Phase 2 | Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer | July 22, 2016 | December 30, 2018 |
| NCT03308552 | Unknown status | Phase 3 | Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02 | December 1, 2017 | August 30, 2021 |
| NCT03474341 | Unknown status | Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer | April 9, 2018 | January 2022 | |
| NCT00876551 | Unknown status | N/A | Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks | January 2008 | December 2012 |
| NCT03579004 | Unknown status | Phase 2 | Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer | July 10, 2017 | July 10, 2020 |
| NCT01151839 | Unknown status | N/A | A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of Oesophagus | June 2010 | |
| NCT04125849 | Unknown status | N/A | Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer | April 2020 | December 2022 |
| NCT01185483 | Unknown status | Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnife | November 2009 | February 2011 | |
| NCT04136236 | Unknown status | Automatic Diagnosis of Early Esophageal Squamous Neoplasia Using pCLE With AI | August 1, 2019 | December 1, 2019 | |
| NCT01646853 | Unknown status | N/A | Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer | August 2012 | |
| NCT04189393 | Unknown status | Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery | January 1, 2020 | November 1, 2021 | |
| NCT01693432 | Unknown status | Phase 2 | Docetaxel and S-1 for Advanced Esophageal Cancer | November 2011 | June 2018 |
| NCT04466631 | Unknown status | Health and Employment After Gastro Intestinal Surgery - HEAGIS2 | June 15, 2020 | April 2021 | |
| NCT04484311 | Unknown status | Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia | August 1, 2020 | December 2020 | |
| NCT01911832 | Unknown status | Phase 3 | Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers | March 2012 | February 2017 |
| NCT02017002 | Unknown status | N/A | Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer | March 2014 | December 2015 |
| NCT04622098 | Unknown status | Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt | November 18, 2020 | January 2022 | |
| NCT02177552 | Unknown status | Phase 2 | Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma | June 2014 | November 2019 |
| NCT04654975 | Unknown status | Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC) | June 2, 2020 | March 31, 2021 | |
| NCT04780256 | Unknown status | Endoscopic Resection of Gastrointestinal Neoplasms | March 15, 2021 | December 2022 | |
| NCT02309619 | Unknown status | N/A | Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE | January 2008 | December 2015 |
| NCT02319187 | Unknown status | Phase 3 | Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial | December 2014 | June 2017 |
| NCT05007145 | Unknown status | Phase 2 | PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | August 15, 2021 | August 31, 2023 |
| NCT05013697 | Unknown status | Phase 2 | TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer. | September 2021 | July 31, 2023 |
| NCT02403050 | Unknown status | Feasibility Study of Fiducial Markers in Oesophageal Cancer | March 2015 | March 2019 | |
| NCT05067153 | Unknown status | Phase 4 | Thromboprophylaxis in Oesophageal Cancer Patients | May 1, 2021 | May 1, 2024 |
| NCT03881111 | Withdrawn | Phase 3 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | January 21, 2019 | May 11, 2022 |
| NCT03787251 | Withdrawn | Phase 2 | A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib | January 1, 2019 | December 31, 2021 |
| NCT00504322 | Withdrawn | Phase 1/Phase 2 | Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma | July 2011 | July 2011 |
| NCT00328887 | Withdrawn | Phase 1 | Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma | November 2004 | July 2010 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004938